Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 325

1.

LATE to the PART-y.

Josephs KA, Mackenzie I, Frosch MP, Bigio EH, Neumann M, Arai T, Dugger BN, Ghetti B, Grossman M, Hasegawa M, Herrup K, Holton J, Jellinger K, Lashley T, McAleese KE, Parisi JE, Revesz T, Saito Y, Vonsattel JP, Whitwell JL, Wisniewski T, Hu W.

Brain. 2019 Jul 29. pii: awz224. doi: 10.1093/brain/awz224. [Epub ahead of print] No abstract available.

PMID:
31359030
2.

Follow-up of active Aβ immunization in Alzheimer disease.

Wisniewski T.

Nat Rev Neurol. 2019 Jul 15. doi: 10.1038/s41582-019-0239-4. [Epub ahead of print] No abstract available.

PMID:
31308505
3.

3T MRI Whole-Brain Microscopy Discrimination of Subcortical Anatomy, Part 2: Basal Forebrain.

Hoch MJ, Bruno MT, Faustin A, Cruz N, Mogilner AY, Crandall L, Wisniewski T, Devinsky O, Shepherd TM.

AJNR Am J Neuroradiol. 2019 Jul;40(7):1095-1105. doi: 10.3174/ajnr.A6088. Epub 2019 Jun 13.

PMID:
31196861
4.

Breakage of metal hip arthroplasty components: Retrieval and structural analysis.

Łapaj Ł, Woźniak W, Wiśniewski T, Rozwalka J, Paczesny Ł, Zabrzyński J, Janusz P, Kruczyński J.

Biomed Mater Eng. 2019;30(3):297-308. doi: 10.3233/BME-191053.

PMID:
31006657
5.

Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer's Disease Mouse Model.

Boutajangout A, Lindberg H, Awwad A, Paul A, Baitalmal R, Almokyad I, Höidén-Guthenberg I, Gunneriusson E, Frejd FY, Härd T, Löfblom J, Ståhl S, Wisniewski T.

Front Aging Neurosci. 2019 Mar 22;11:64. doi: 10.3389/fnagi.2019.00064. eCollection 2019.

6.

Novel Mouse Tauopathy Model for Repetitive Mild Traumatic Brain Injury: Evaluation of Long-Term Effects on Cognition and Biomarker Levels After Therapeutic Inhibition of Tau Phosphorylation.

Rubenstein R, Sharma DR, Chang B, Oumata N, Cam M, Vaucelle L, Lindberg MF, Chiu A, Wisniewski T, Wang KKW, Meijer L.

Front Neurol. 2019 Mar 11;10:124. doi: 10.3389/fneur.2019.00124. eCollection 2019.

7.

3T MRI Whole-Brain Microscopy Discrimination of Subcortical Anatomy, Part 1: Brain Stem.

Hoch MJ, Bruno MT, Faustin A, Cruz N, Crandall L, Wisniewski T, Devinsky O, Shepherd TM.

AJNR Am J Neuroradiol. 2019 Mar;40(3):401-407. doi: 10.3174/ajnr.A5956. Epub 2019 Jan 31.

PMID:
30705073
8.

Comparative analysis of cognitive impairment prevalence and its etiological subtypes in a rural area of northern China between 2010 and 2015.

Lu H, Wang XD, Shi Z, Yue W, Zhang Y, Liu S, Liu S, Zhao L, Xiang L, Zhang Y, Guan Y, Su W, Li Z, Wang J, Wisniewski T, Ji Y.

Sci Rep. 2019 Jan 29;9(1):851. doi: 10.1038/s41598-018-37286-z.

9.

Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment).

Reisberg B, Torossian C, Shulman MB, Monteiro I, Boksay I, Golomb J, Guillo Benarous F, Ulysse A, Oo T, Vedvyas A, Rao JA, Marsh K, Kluger A, Sangha J, Hassan M, Alshalabi M, Arain F, Shaikh N, Buj M, Kenowsky S, Masurkar AV, Rabin L, Noroozian M, Sánchez-Saudinós MAB, Blesa R, Auer S, Zhang Y, de Leon M, Sadowski M, Wisniewski T, Gauthier S, Shao Y.

J Alzheimers Dis. 2019;67(2):685-705. doi: 10.3233/JAD-180341.

PMID:
30689585
10.

ADAMTS18 Deficiency Affects Neuronal Morphogenesis and Reduces the Levels of Depression-like Behaviors in Mice.

Zhu R, Pan YH, Sun L, Zhang T, Wang C, Ye S, Yang N, Lu T, Wisniewski T, Dang S, Zhang W.

Neuroscience. 2019 Feb 10;399:53-64. doi: 10.1016/j.neuroscience.2018.12.025. Epub 2018 Dec 21.

PMID:
30579834
11.

Deficit of corpus callosum axons, reduced axon diameter and decreased area are markers of abnormal development of interhemispheric connections in autistic subjects.

Wegiel J, Kaczmarski W, Flory M, Martinez-Cerdeno V, Wisniewski T, Nowicki K, Kuchna I, Wegiel J.

Acta Neuropathol Commun. 2018 Dec 19;6(1):143. doi: 10.1186/s40478-018-0645-7.

12.

A cross-species approach to disorders affecting brain and behaviour.

Devinsky O, Boesch JM, Cerda-Gonzalez S, Coffey B, Davis K, Friedman D, Hainline B, Houpt K, Lieberman D, Perry P, Prüss H, Samuels MA, Small GW, Volk H, Summerfield A, Vite C, Wisniewski T, Natterson-Horowitz B.

Nat Rev Neurol. 2018 Nov;14(11):677-686. doi: 10.1038/s41582-018-0074-z. Review.

13.

A Population-Based Approach to Mapping Vulnerability to Diabetes.

Linder S, Marko D, Tian Y, Wisniewski T.

Int J Environ Res Public Health. 2018 Oct 2;15(10). pii: E2167. doi: 10.3390/ijerph15102167.

14.

Osteopontin And Angiogenic Factors As New Biomarkers Of Prostate Cancer.

Wisniewski T, Zyromska A, Makarewicz R, Zekanowska E.

Urol J. 2019 May 5;16(2):134-140. doi: 10.22037/uj.v0i0.4282.

15.

The role of reduced expression of fragile X mental retardation protein in neurons and increased expression in astrocytes in idiopathic and syndromic autism (duplications 15q11.2-q13).

Wegiel J, Brown WT, La Fauci G, Adayev T, Kascsak R, Kascsak R, Flory M, Kaczmarski W, Kuchna I, Nowicki K, Martinez-Cerdeno V, Wisniewski T, Wegiel J.

Autism Res. 2018 Oct;11(10):1316-1331. doi: 10.1002/aur.2003. Epub 2018 Aug 14.

PMID:
30107092
16.

Intracranial plasmacytoma presenting as glioblastoma multiforme.

Wiśniewski T, Żyromska A, Birski M, Szylberg T, Makarewicz R.

Neurol Neurochir Pol. 2018 Aug;52(4):543-545. doi: 10.1016/j.pjnns.2018.06.005. Epub 2018 Jul 3. No abstract available.

PMID:
30025720
17.

Recent advancements toward therapeutic vaccines against Alzheimer's disease.

Herline K, Drummond E, Wisniewski T.

Expert Rev Vaccines. 2018 Aug;17(8):707-721. doi: 10.1080/14760584.2018.1500905. Epub 2018 Aug 9. Review.

PMID:
30005578
18.

Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.

Herline K, Prelli F, Mehta P, MacMurray C, Goñi F, Wisniewski T.

Alzheimers Res Ther. 2018 Jun 18;10(1):54. doi: 10.1186/s13195-018-0384-9.

19.

Vaccination strategies.

Wisniewski T, Goñi F.

Handb Clin Neurol. 2018;153:419-430. doi: 10.1016/B978-0-444-63945-5.00023-4.

PMID:
29887149
20.

Carbonic anhydrase inhibition selectively prevents amyloid β neurovascular mitochondrial toxicity.

Solesio ME, Peixoto PM, Debure L, Madamba SM, de Leon MJ, Wisniewski T, Pavlov EV, Fossati S.

Aging Cell. 2018 Aug;17(4):e12787. doi: 10.1111/acel.12787. Epub 2018 Jun 5.

21.

Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease.

Drummond E, Goñi F, Liu S, Prelli F, Scholtzova H, Wisniewski T.

J Alzheimers Dis. 2018;64(s1):S299-S312. doi: 10.3233/JAD-179909. Review.

PMID:
29562516
22.

Generation and Partial Characterization of Rabbit Monoclonal Antibody to Pyroglutamate Amyloid-β3-42 (pE3-Aβ).

Mehta PD, Patrick BA, Barshatzky M, Mehta SP, Frackowiak J, Mazur-Kolecka B, Wegiel J, Wisniewski T, Miller DL.

J Alzheimers Dis. 2018;62(4):1635-1649. doi: 10.3233/JAD-170898.

PMID:
29504532
23.

Thymoma-associated panencephalitis: a newly emerging paraneoplastic neurologic syndrome.

Nwabuobi LA, Pellinen JC, Wisniewski TM.

Neuroimmunol Neuroinflamm. 2017;4:117-123. doi: 10.20517/2347-8659.2016.53. Epub 2017 Jun 16.

24.

15O-H2O PET/CT as a tool for the quantitative assessment of early post-radiotherapy changes of heart perfusion in breast carcinoma patients.

Żyromska A, Małkowski B, Wiśniewski T, Majewska K, Reszke J, Makarewicz R.

Br J Radiol. 2018 Jul;91(1088):20170653. doi: 10.1259/bjr.20170653. Epub 2018 Jul 20.

25.

Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link.

Ramos-Cejudo J, Wisniewski T, Marmar C, Zetterberg H, Blennow K, de Leon MJ, Fossati S.

EBioMedicine. 2018 Feb;28:21-30. doi: 10.1016/j.ebiom.2018.01.021. Epub 2018 Jan 31. Review.

26.

Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model.

Goñi F, Martá-Ariza M, Herline K, Peyser D, Boutajangout A, Mehta P, Drummond E, Prelli F, Wisniewski T.

Alzheimers Res Ther. 2018 Jan 29;10(1):10. doi: 10.1186/s13195-018-0337-3.

27.

Isolation of Amyloid Plaques and Neurofibrillary Tangles from Archived Alzheimer's Disease Tissue Using Laser-Capture Microdissection for Downstream Proteomics.

Drummond E, Nayak S, Pires G, Ueberheide B, Wisniewski T.

Methods Mol Biol. 2018;1723:319-334. doi: 10.1007/978-1-4939-7558-7_18.

28.

Is multiple system atrophy an infectious disease?

Wenning G, Trojanowski JQ, Kaufmann H, Wisniewski T, Rocca WA, Low PA.

Ann Neurol. 2018 Jan;83(1):10-12. doi: 10.1002/ana.25132. Epub 2018 Jan 14. No abstract available.

29.

Primary care physicians' utilization of type 2 diabetes screening guidelines and referrals to behavioral interventions: a survey-linked retrospective study.

Mehta S, Mocarski M, Wisniewski T, Gillespie K, Narayan KMV, Lang K.

BMJ Open Diabetes Res Care. 2017 Aug 11;5(1):e000406. doi: 10.1136/bmjdrc-2017-000406. eCollection 2017.

30.

Production of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases.

Goñi F, Martá-Ariza M, Peyser D, Herline K, Wisniewski T.

Sci Rep. 2017 Aug 29;7(1):9881. doi: 10.1038/s41598-017-10393-z.

31.

Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer's Disease Related Pathology and Cognitive Decline.

Liu S, Park S, Allington G, Prelli F, Sun Y, Martá-Ariza M, Scholtzova H, Biswas G, Brown B, Verghese PB, Mehta PD, Kwon YU, Wisniewski T.

Sci Rep. 2017 Aug 14;7(1):8009. doi: 10.1038/s41598-017-08604-8.

32.

The use of localized proteomics to identify the drivers of Alzheimer's disease pathogenesis.

Drummond E, Wisniewski T.

Neural Regen Res. 2017 Jun;12(6):912-913. doi: 10.4103/1673-5374.208570. No abstract available.

33.

Multiregional Age-Associated Reduction of Brain Neuronal Reserve Without Association With Neurofibrillary Degeneration or β-Amyloidosis.

Wegiel J, Flory M, Kuchna I, Nowicki K, Yong Ma S, Wegiel J, Badmaev E, Silverman WP, de Leon M, Reisberg B, Wisniewski T.

J Neuropathol Exp Neurol. 2017 Jun 1;76(6):439-457. doi: 10.1093/jnen/nlx027.

34.

Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein.

Rubenstein R, Chang B, Grinkina N, Drummond E, Davies P, Ruditzky M, Sharma D, Wang K, Wisniewski T.

Acta Neuropathol Commun. 2017 Apr 18;5(1):30. doi: 10.1186/s40478-017-0435-7.

35.

Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension.

Hoyt SB, Taylor J, London C, Ali A, Ujjainwalla F, Tata J, Struthers M, Cully D, Wisniewski T, Ren N, Bopp C, Sok A, Verras A, McMasters D, Chen Q, Tung E, Tang W, Salituro G, Clemas J, Zhou G, MacNeil D, Duffy R, Xiong Y.

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2384-2388. doi: 10.1016/j.bmcl.2017.04.021. Epub 2017 Apr 8.

PMID:
28416132
36.

Partial Agenesis and Hypoplasia of the Corpus Callosum in Idiopathic Autism.

Wegiel J, Flory M, Kaczmarski W, Brown WT, Chadman K, Wisniewski T, Nowicki K, Kuchna I, Ma SY, Wegiel J.

J Neuropathol Exp Neurol. 2017 Mar 1;76(3):225-237. doi: 10.1093/jnen/nlx003.

37.

Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease.

Drummond E, Nayak S, Faustin A, Pires G, Hickman RA, Askenazi M, Cohen M, Haldiman T, Kim C, Han X, Shao Y, Safar JG, Ueberheide B, Wisniewski T.

Acta Neuropathol. 2017 Jun;133(6):933-954. doi: 10.1007/s00401-017-1691-0. Epub 2017 Mar 4.

38.

Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits.

Scholtzova H, Do E, Dhakal S, Sun Y, Liu S, Mehta PD, Wisniewski T.

J Neurosci. 2017 Jan 25;37(4):936-959. doi: 10.1523/JNEUROSCI.1967-16.2016.

39.

Discovery of Spirocyclic Aldosterone Synthase Inhibitors as Potential Treatments for Resistant Hypertension.

Petrilli WL, Hoyt SB, London C, McMasters D, Verras A, Struthers M, Cully D, Wisniewski T, Ren N, Bopp C, Sok A, Chen Q, Li Y, Tung E, Tang W, Salituro G, Knemeyer I, Karanam B, Clemas J, Zhou G, Gibson J, Shipley CA, MacNeil DJ, Duffy R, Tata JR, Ujjainwalla F, Ali A, Xiong Y.

ACS Med Chem Lett. 2016 Nov 22;8(1):128-132. doi: 10.1021/acsmedchemlett.6b00455. eCollection 2017 Jan 12.

40.

Alzheimer's disease: experimental models and reality.

Drummond E, Wisniewski T.

Acta Neuropathol. 2017 Feb;133(2):155-175. doi: 10.1007/s00401-016-1662-x. Epub 2016 Dec 26. Review.

41.

Imidazopyridyl compounds as aldosterone synthase inhibitors.

Whitehead BR, Lo MM, Ali A, Park MK, Hoyt SB, Xiong Y, Cai J, Carswell E, Cooke A, MacLean J, Ratcliffe P, Robinson J, Bennett DJ, Clemas JA, Wisniewski T, Struthers M, Cully D, MacNeil DJ.

Bioorg Med Chem Lett. 2017 Jan 15;27(2):143-146. doi: 10.1016/j.bmcl.2016.12.003. Epub 2016 Dec 2.

PMID:
27979595
42.

A Systematic Review of Insulin Adherence Measures in Patients with Diabetes.

Stolpe S, Kroes MA, Webb N, Wisniewski T.

J Manag Care Spec Pharm. 2016 Nov;22(11):1224-1246. Review.

43.
44.

Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics.

Hickman RA, Faustin A, Wisniewski T.

Neurol Clin. 2016 Nov;34(4):941-953. doi: 10.1016/j.ncl.2016.06.009. Epub 2016 Aug 4. Review.

45.

State-dependent alterations in cerebrospinal fluid Aβ42 levels in cognitively intact elderly with late-life major depression.

Pomara N, Bruno D, Osorio RS, Reichert C, Nierenberg J, Sarreal AS, Hernando RT, Marmar CR, Wisniewski T, Zetterberg H, Blennow K.

Neuroreport. 2016 Sep 28;27(14):1068-71. doi: 10.1097/WNR.0000000000000658.

46.

Response by Dr. Lapaj to comment on Lapaj et al.: Retrieval analysis of titanium nitride (TiN) coated prosthetic femoral heads articulating with polyethylene.

Łapaj Ł, Wendland J, Markuszewski J, Mróz A, Wiśniewski T.

J Mech Behav Biomed Mater. 2016 Oct;63:478-481. doi: 10.1016/j.jmbbm.2016.04.026. Epub 2016 Jun 23. Review. No abstract available.

PMID:
27381845
47.

Clearance systems in the brain--implications for Alzheimer diseaser.

Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV, Frangione B, Blennow K, Ménard J, Zetterberg H, Wisniewski T, de Leon MJ.

Nat Rev Neurol. 2016 Apr;12(4):248. doi: 10.1038/nrneurol.2016.36. Epub 2016 Mar 29. No abstract available.

PMID:
27020556
48.

The Cox-2 Inhibitor Meloxicam Ameliorates Neuroinflammation and Depressive Behavior in Adult Mice after Splenectomy.

Haile M, Boutajangout A, Chung K, Chan J, Stolper T, Vincent N, Batchan M, D'Urso J, Lin Y, Kline R, Yaghmoor F, Jahfal S, Kamal R, Aljohani W, Blanck T, Bekker A, Wisniewski T.

J Neurophysiol Neurol Disord. 2016;3. pii: 101. Epub 2016 Aug 5.

49.

Application of ultrasound examination in tactical conditions illustrated with an example of the Field Hospital of the Polish Military Contingent in Afghanistan.

Machała W, Wiśniewski T, Brzozowski R.

J Ultrason. 2014 Dec;14(59):393-401. doi: 10.15557/JoU.2014.0040. Epub 2014 Dec 30. Review.

50.

Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, Murray ME, Nelson PT, Takahashi H, Trojanowski JQ, Ansorge O, Arzberger T, Baborie A, Beach TG, Bieniek KF, Bigio EH, Bodi I, Dugger BN, Feany M, Gelpi E, Gentleman SM, Giaccone G, Hatanpaa KJ, Heale R, Hof PR, Hofer M, Hortobágyi T, Jellinger K, Jicha GA, Ince P, Kofler J, Kövari E, Kril JJ, Mann DM, Matej R, McKee AC, McLean C, Milenkovic I, Montine TJ, Murayama S, Lee EB, Rahimi J, Rodriguez RD, Rozemüller A, Schneider JA, Schultz C, Seeley W, Seilhean D, Smith C, Tagliavini F, Takao M, Thal DR, Toledo JB, Tolnay M, Troncoso JC, Vinters HV, Weis S, Wharton SB, White CL 3rd, Wisniewski T, Woulfe JM, Yamada M, Dickson DW.

Acta Neuropathol. 2016 Jan;131(1):87-102. doi: 10.1007/s00401-015-1509-x. Epub 2015 Dec 10. Review.

Supplemental Content

Loading ...
Support Center